Clinical Trial Update: Study Investigating Rapamune For Post-Marketing Surveillance

View source ↗

Summary

Pfizer-sponsored post-marketing surveillance study evaluating Rapamune (sirolimus) in kidney transplant recipients has completed and posted its results. The res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Pfizer | Conditions: Kidney Transplantation | Status: COMPLETED | Results posted: 2017-01-16